<DOC>
	<DOCNO>NCT01627483</DOCNO>
	<brief_summary>The aim study investigate prescribe fall-risk increase fracture-preventing drug improve old hip fracture patient assessment risk fall fracture medication review perform physician forward prescribing physician .</brief_summary>
	<brief_title>Randomized Controlled Trial Effects Physician 's Medication Reviews Prescribing Older Hip Fracture Patients</brief_title>
	<detailed_description>The patient recruit postsurgery . They randomly allocate intervention control group ( 1:1 ) . Sequentially numbered , opaque , seal envelope open sequentially participant detail write envelope . Carbon paper inside envelope transfer information assignment card . Two person involve study without knowledge study protocol perform randomization procedure . The patient inform result randomization . Intervention By short interview and/or extraction information medical record comprehensive assessment risk fall risk fracture . Thereafter medication review focus fall-risk-increasing fracture-preventing drug perform . The result assessment medication review forward orally write prescribing physician . The recipient physician ward inhospital care general practitioner three six month surgery . Data collection Prescribing drug Data obtain medical record Sahlgrenska University Hospital , medical record general practitioner , multi-dose drug dispense list , , Swedish Prescribed Drugs Register ( Läkemedelsförteckningen ) . Patient data Information patient hospital stay follow-up period obtain medical record hospital , medical record general practitioner , Swedish National Hip Fracture Register ( RIKSHÖFT ) , health care database Region Västra Götaland . Data medical care contact due fall accident obtain care database Western Region ( VEGA database ) . Additionally , data diagnosis obtain National Patient Register ( Patientregistret ) . For deceased patient , data Cause Death Register ( Dödsorsaksregistret ) obtain . Physicians attitudes A short questionnaire administer physician hospital general practitioner . The questionnaire answer anonymously include question attitude towards intervention usefulness . A reminder administer two week later . Power calculation The study power &gt; 80 % detect 50 % rise prescribe fracture-preventing drug intervention group , double bisphosphonates bone specific drug reduction 15 % mean ( SD ) number fall-risk increase drug . Power calculation base assumption drug treatment control group improve 30 % fracture-preventing drug 60 % bisphosphonates compare study perform 2008 .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<criteria>hip fracture surgery Sahlgrenska University Hospital/Mölndal age 65 year reside Gothenburg area opposition participation able give inform consent , opposition participation next kin</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>elderly</keyword>
	<keyword>hip fracture</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>fall risk</keyword>
	<keyword>medication review</keyword>
</DOC>